Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients
NCT00333021 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 127
Last updated 2009-07-10
Summary
This study is phase 3 study for prevention of VTE in patients with abdominal surgery.
Conditions
- Venous Thromboembolism
Interventions
- DRUG
-
Fondaparinux sodium
- DRUG
-
GSK576428
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, MD · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-31
- Completion
- 2007-02-28
Countries
- Japan
Study Locations
More Related Trials
-
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery
NCT01390896 ·Status: COMPLETED
-
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
NCT00789399 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).
NCT00038961 ·Status: COMPLETED ·Phase: PHASE3
-
Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
NCT00723216 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
NCT01444612 ·Status: COMPLETED
-
Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy
NCT00539942 ·Status: TERMINATED ·Phase: PHASE3
-
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
NCT00531843 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)
NCT01390883 ·Status: COMPLETED
-
Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
NCT00894283 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients
NCT00493896 ·Status: TERMINATED ·Phase: PHASE3
-
Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism
NCT01004939 ·Status: COMPLETED
-
Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia
NCT01727401 ·Status: TERMINATED ·Phase: PHASE4
-
SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT05752461 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Determine Effective Dosing of Fondaparinux in Obese Persons
NCT00346879 ·Status: WITHDRAWN ·Phase: PHASE1
-
Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection
NCT01420809 ·Status: COMPLETED
-
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
NCT00679588 ·Status: COMPLETED ·Phase: PHASE3
-
Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
NCT00413504 ·Status: COMPLETED ·Phase: NA
-
OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction
NCT00064428 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
NCT00443053 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
NCT00843492 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs
NCT01857583 ·Status: COMPLETED ·Phase: PHASE3
-
Determination of Residual Anticoagulatory Effects of Fondaparinux
NCT01101256 ·Status: UNKNOWN
-
Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients
NCT06443905 ·Status: ACTIVE_NOT_RECRUITING
-
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT06825416 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery
NCT01308528 ·Status: COMPLETED ·Phase: PHASE3